ProfileGDS4177 / 235105_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 45% 42% 47% 47% 39% 40% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated27.1245
GSM603099KU-812 non-treated23.1542
GSM603098KCL-22 Imatinib-treated28.8547
GSM603097KCL-22 non-treated27.9547
GSM603102JURL-MK1 Imatinib-treated20.7639
GSM603101JURL-MK1 non-treated21.8540